HOME >> BIOLOGY >> NEWS
Magnetic field exposure associated with childhood leukemia

Researchers at the University of Toronto and the Hospital for Sick Children have found an association between magnetic field exposures in residences and the risk of developing childhood leukemia.

The study, reported in two separate papers in the current issues of the International Journal of Cancer (IJC) and the journal Cancer Causes and Control (CCC), shows that children with higher exposures to magnetic fields in residences are two to four times more likely to develop leukemia compared to children who are less exposed. The study comprehensively measured magnetic field exposures inside and outside the children's homes. Wire code was also assigned to each residence. For some children, EMF exposures were measured by a personal monitor.

The authors report in IJC that overall, wire code -- a surrogate indicator of magnetic field exposure based on the physical characteristics of the line and proximity of the residence to power lines -- was not associated with an increased risk of developing leukemia. However, leukemia risk was elevated for children diagnosed at less than six years of age in relation to magnetic field exposures in residences occupied during the first two years of life.

A subset of the total study population wore a personal monitoring device which measured EMF during usual activities in the home over 48 hours. As reported in CCC, exposure to magnetic fields was associated with a two-fold increase in risk of developing leukemia.

When other factors such as residential mobility, power consumption, child's medical history and other environmental exposures were taken into account, children exposed to higher levels of magnetic fields were 4.5 times more likely to develop leukemia compared to less exposed children. Risks were higher for children diagnosed at less than six years of age and for those with acute lymphoblastic leukemia -- the most common type of leukemia in children.

"As t
'"/>

Contact: Steven de Sousa
steven.desousa@utoronto.ca
416-978-5949
University of Toronto
16-Jun-1999


Page: 1 2

Related biology news :

1. Magnetic tag lets scientists track stem cells in living rat
2. Magnetic fluids offer hope for treatment of retinal detachment
3. Magnetic fields may hold key to malaria treatment, UW researchers find
4. Magnetic resonance imaging of sexual intercourse is both possible and useful...
5. Magnetic Fluids More Complex Than Previously Thought
6. Report On Electrical And Magnetic Fields Released; Public Invited To Comment At Regional Meetings
7. Scientists Use Magnetic Field As Alternative To Space-Based Zero Gravity
8. Moving DNA Molecules With Magnetic Tweezers
9. Newly Discovered Bacteria Produce Magnetic Material
10. Health of worlds sea lions the focus of Wakefield Symposium
11. From orchards and fields to townhouses and offices

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Magnetic field exposure associated with childhood leukemia

(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
(Date:12/10/2014)... 8, 2014 You,ve been here before: you desperately ... remember your password, site key or the answer to your ... grade teacher? Today, Hoyos Labs , ... that will finally put an end to the frustration that ... . 1U leverages a user,s smartphone to acquire his ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: